Yahoo

Stepan (SCL) Could Be 18% Below Fair Value After Strong Q3 Results And Dividend Hike

Why Stepan Stock Is Back On Investors' Radar

Stepan (SCL) is drawing fresh attention after third quarter results showed higher sales, stronger earnings from continuing operations, and company wide organic volume growth, alongside a higher cash dividend for the 59th straight year.

Recent trading reflects that story. The share price has climbed 48.41% year to date to US$69.99, with a 12.54% 1 month share price return and 9.12% 3 month share price return. The 1 year total shareholder return of 68.10% contrasts with a 5 year total shareholder return that is still down 37.79%.

Scan beyond Stepan and see how other chemicals and materials players with momentum and fundamentals stack up in our curated 30 high quality undervalued stocks .

After a 68.10% 1 year total return and a sharp move off the lows, the real tension around Stepan now is simple: Is most of the re rating already behind it, or does the current valuation still point to meaningful upside ahead?

Most Popular Narrative: 18% Undervalued

Stepan's most followed narrative pins fair value at $85 per share, above the last close of $69.99. This puts the recent rally in a different light for anyone focused on long run cash generation and balance sheet flexibility.

The analysts have a consensus price target of $85.0 for Stepan based on their expectations of its future earnings growth, profit margins and other risk factors.

In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $2.8 billion, earnings will come to $305.5 million, and it would be trading on a PE ratio of 8.1x, assuming you use a discount rate of 8.1%.

See why 6 investors see Stepan as 18% undervalued .

Result: Fair Value of $85 (UNDERVALUED)

Still, high interest rates that restrain rigid polyol demand and any renewed spike in coconut oil costs could quickly pressure Stepan's margins and challenge that 18% undervaluation story.

Find out about the key risks to this Stepan narrative .

Next Steps

Mixed signals around Stepan's valuation can feel confusing, so move quickly to review the full data set and weigh both sides of the story for yourself using 2 key rewards and 2 important warning signs .

Looking For More Investment Ideas Beyond Stepan?

If Stepan has sharpened your focus on quality, do not stop here. Broader opportunity often sits just outside the stocks already on your screen.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SCL .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: